Adrien Brochier--Allari

Growth at NanoCorp

📍 Nice, Provence-Alpes-Cote d'Azur, France🔄 Updated September 2026💼 2 investments📅 7 years investing🗓 Last invested Sep 2019
VC🌍 France
2
Total investments
1
Early stage
0
Mid stage
1
Late stage
7y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Sep 2019
Were hiring worldwide! https://wandercraft.welcomekit.co/ At Wandercraft, we believe movement is freedom. Since 2012, our mission has been simple but bold: restore mobility where it’s been lost, and expand what’s possible with robotics that move like people do. We see robotics as the ultimate partners—machines that can do what humans cannot, or should not, do. That means giving back the ability to walk to someone with a spinal cord injury, or stepping in on a factory floor where work is too heavy, repetitive, or hazardous. We pioneered the world’s first self-balancing exoskeleton—technology that doesn’t rely on crutches or walkers, but lets people stand and walk freely. Today, our work goes beyond healthcare. From rehabilitation centers to factory floors, and soon into homes and communities, we’re shaping a future where humans and robots move forward together. Our technology, powered by physical AI and 30+ patents, is life-tested in the most demanding environments: real people, real steps, real work. Meet our devices: Atalante X – A self-balancing exoskeleton enabling hundreds of patients with mobility disabilities to take over 1 million steps per month in 100+ leading hospitals and research centers worldwide. It is designed to promote upright posture, cardiovascular health, neuroplasticity, and—most importantly—upright independence. Eve – The world’s first self-balancing exoskeleton for personal use. Designed for daily life, Eve enables individuals with severe mobility impairments to walk hands-free at home and outdoors. Currently in U.S. clinical trials, Eve is expected to launch in 2026. Calvin-40 – Our first industrial humanoid robot. Autonomous and voice-operated, Calvin-40 is built to take on physically demanding or hazardous tasks in non-ergonomic environments. Based on the same platform as our exoskeletons, Calvin is already hard at work with Renault Group and more.
Private Investor
Aug 2019
Founded in 2018, Posos is a MedTech company that has built the worlds most advanced artificial intelligence platform dedicated to medical prescriptions. It seamlessly integrates into a hospital’s electronic medical records, enabling healthcare prescribers to use AI to prescribe in real-time, based on the best recommendations. Co-created by Posos pharmacists and engineers, the platform has received approval from health authorities in France. Its powerful AI assistant speeds up and optimizes the prescribing process, which is currently very time-consuming and approximate within EHR. Posos can drive massive patient and economic impact, as demonstrated by the numerous EU institutions that have already adopted the solution.
Experience · 9 entries
All (9)
Investments (2)
Founder (4)
2025
Founder & CEO
Oct 2025
A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered
2023
Co-Founder & CEO
Jan 2023
Vivaldy est une plateforme d'acquisition et de gestion de résidences secondaires partagées. Nous démocratisons l'accès aux résidences secondaires en vous permettant de les partager avec des personnes de confiance 🤝 - Achetez plus de biens avec le même budget 💸 - Divisez vos frais d’entretien et vos taxes ➗ - Profitez de vos vacances dans VOTRE propriété 🏝 - Un investissement locatif ou un achat plaisir ? Plus besoin de choisir ! Profitez ou louez selon vos envies 🏡 - Investissez dans un bien que vous pourrez revendre plutôt que dépenser plusieurs milliers d’euros, que vous ne reverrez jamais, dans une location 🏛 Pour en savoir plus : www.vivaldy.co
early stageReal Estate
2022
Private Equity - Intern
Jul 2022
Tikehau Capital is a global alternative asset management group with €50.6 billion of assets under management (at 31 March 2025). Tikehau Capital has developed a wide range of expertise across four asset classes (credit, real assets, private equity and capital markets strategies) as well as multi-asset and special opportunities strategies. Tikehau Capital is a founder-led team with a differentiated business model, a strong balance sheet, proprietary global deal flow and a track record of backing high quality companies and executives. Deeply rooted in the real economy, Tikehau Capital provides bespoke and innovative alternative financing solutions to companies it invests in and seeks to create long-term value for its investors, while generating positive impacts on society. Leveraging its strong equity base (€3.2 billion of shareholders’ equity at 31 December 2024), the firm invests its own capital alongside its investor-clients within each of its strategies. Controlled by its managers alongside leading institutional partners, Tikehau Capital is guided by a strong entrepreneurial spirit and DNA, shared by its 747 employees (at 31 March 2025) across its 17 offices in Europe, the Middle East, Asia and North America. Tikehau Capital is listed in compartment A of the regulated Euronext Paris market (ISIN code: FR0013230612; Ticker: TKO.FP). For more information, please visit: www.tikehaucapital.com.
2021
M&A and Strategy - Intern
Jan 2021
We’re one of the world’s largest privately owned real estate tech companies and a subsidiary of Axel Springer. Our mission is to unlock everyone’s perfect place! Some of Europe’s best known digital real estate marketplaces and brands form part of our Group, they are: 🇫🇷 Meilleurs Agents 🇫🇷 Groupe SeLoger 🇧🇪 Immoweb 🇧🇪 Realo 🇩🇪 Immowelt 🇩🇪 Neuraum 🇮🇱 Yad2 Our ambition is to be the leading employer in #proptech in Europe. Check out our social posts and career opportunities to become an AVIVer 🤩
2019
Private Investor
Sep 2019
Were hiring worldwide! https://wandercraft.welcomekit.co/ At Wandercraft, we believe movement is freedom. Since 2012, our mission has been simple but bold: restore mobility where it’s been lost, and expand what’s possible with robotics that move like people do. We see robotics as the ultimate partners—machines that can do what humans cannot, or should not, do. That means giving back the ability to walk to someone with a spinal cord injury, or stepping in on a factory floor where work is too heavy, repetitive, or hazardous. We pioneered the world’s first self-balancing exoskeleton—technology that doesn’t rely on crutches or walkers, but lets people stand and walk freely. Today, our work goes beyond healthcare. From rehabilitation centers to factory floors, and soon into homes and communities, we’re shaping a future where humans and robots move forward together. Our technology, powered by physical AI and 30+ patents, is life-tested in the most demanding environments: real people, real steps, real work. Meet our devices: Atalante X – A self-balancing exoskeleton enabling hundreds of patients with mobility disabilities to take over 1 million steps per month in 100+ leading hospitals and research centers worldwide. It is designed to promote upright posture, cardiovascular health, neuroplasticity, and—most importantly—upright independence. Eve – The world’s first self-balancing exoskeleton for personal use. Designed for daily life, Eve enables individuals with severe mobility impairments to walk hands-free at home and outdoors. Currently in U.S. clinical trials, Eve is expected to launch in 2026. Calvin-40 – Our first industrial humanoid robot. Autonomous and voice-operated, Calvin-40 is built to take on physically demanding or hazardous tasks in non-ergonomic environments. Based on the same platform as our exoskeletons, Calvin is already hard at work with Renault Group and more.
Show all 9 entries ↓